Societal preferences for adjuvant melanoma health states: UK and Australia

No studies have measured preference-based utility weights for specific toxicities and outcomes associated with approved and investigational adjuvant treatments for patients with resected high-risk melanoma. | Societal preferences for adjuvant melanoma health states UK and Australia

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN